UPCC 60424 Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Research Study on Blood Stem Cell Transplants and Related Therapies

Enrolling By Invitation
99 years or below
All
Phase N/A
1 Location

Brief description of study

TBD

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

The purpose of this study is to investigate hematopoietic cell transplantation, other cellular therapies, and marrow toxic injuries. This procedure involves receiving blood-forming stem cells to restore bone marrow function, often used for treating certain cancers and blood disorders.

Participants in this study will undergo various procedures related to the collection and analysis of samples. These samples will contribute to a research repository aimed at improving the understanding of hematopoietic cell transplantation and related therapies.

  • Who can participate: Eligibility criteria for this study are to be determined. Specific age criteria and key eligibility factors will be provided once available.
  • Study details: Participants will be involved in the collection of samples that will be stored in a research repository. The study focuses on understanding the effects and outcomes of hematopoietic cell transplantation and related therapies.
Updated on 22 Apr 2026. Study ID: 02-0003
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator